Assessment of the role of neutrophils on the antitumor effect of TNFα in an in vivo isolated limb perfusion model sarcoma-bearing brown Norway rats

Journal of Surgical Research

Volumn 78, Issue 2, 1998, Pages 169-175

  Manusama, E R ^a   Nooijen, P T G A ^b   Stavast, J ^a   De Wilt, J H W ^a   Marquet, R L ^a   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Chemotherapy; Oncology

Indexed keywords

MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LEUKOCYTE COUNT; LIMB PERFUSION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REMISSION; SARCOMA; SKIN NECROSIS; THROMBOCYTE AGGREGATION; TUMOR IMMUNOLOGY;

EID: 0344906175     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5256     Document Type: Article

References (34)

1. Lienard D., Ewalenko P., Delmotte J. J., Renard N., Lejeune F. J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10:1992;52.
2. Lejeune F. J., Liénard D., Eggermont A. M. M. Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. Circ. Shock. 43:1994;191.
3. Eggermont A. M. M., Lienard D., Schrafford Koops H., Rosenkaimer F., Lejeune F. J. Treatment of irresectable soft tissue sarcomas of the limbs by isolation perfusion with high dose TNFα in combination with gamma-interferon and melphalan. Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. 1993;Karger Verlag, Basel. p. 239-243.
4. Eggermont A. M. M., Schraffordt Koops H., Lienard D., Kroon B. B. R., Van Geel A. N., Hoekstra H. J., Lejeune F. J. Isolated limb perfusion with high dose tumor necrosis factor-α in combination with interferon-γ and melphalan for irresectable extremity soft tissue sarcomas: A multicenter trial. J. Clin. Oncol. 14:1996;2653.
5. Renard N., Lienard D., Lespagnard L., Eggermont A., Heimann R., Lejeune F. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα). Int. J. Cancer. 57:1994;656.
6. Eggermont A. M. M., Schraffordt Koops H., Lienard D., Lejeune F. J., Oukerk M. Angiographic observations before and after high dose TNFα isolated limb perfusion in patients with extremity soft tissue sarcomas. Eur. J. Surg. Oncol. 20:1994;403.
7. Manusama E. R., Durante N. M. C., Marquet R. L., Eggermont A. M. M. Ischemia promotes the antitumor effect tumor necrosis factor alpha (TNFα) in isolated limb perfusion in the rat. Reg. Cancer Treat. 7:1994;155.
8. Manusama E. R., Nooijen P. T. G. A., Stavast J., Durante N. M. C., Marquet R. L., Eggermont A. M. M. Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat. Br. J. Surg. 83:1996;551.
9. Nooijen P. T. G. A., Manusama E. R., Eggermont A. M. M., Schalkwijk L., Stavast J., Marquet R. L., de Waal R. M. W., Ruiter D. J. Synergistic effects of TNFα and melphalan in an isolated limb perfusion model of rat sarcoma. A histopathological, immunohistochemical and electron microscopical study. Br. J. Cancer. 74:1996;1908.
10. Nawroth P., Handley D., Matsueda G., Gerlach H., Blohm D., Stern D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J. Exp. Med. 168:1988;637.
11. Shimomura K., Manda T., Mukumoto S., Kobayashi K., Nakano K., Mori J. Recombinant human tumor necrosis factor-alpha: Thrombus formation is a cause of anti-tumor activity. Int. J. Cancer. 41:1988;243.
12. Proietti E., Belardelli F., Carpinelli G. Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in mice. Int. J. Cancer. 42:1988;582.
13. Watanabe N., Niitsu Y., Umeno H. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 48:1988;2179.
14. Marquet R. L., Schellekens H., Westbroek D. L., Jeekel J. Effect of treatment with interferon and cyclophosphamide on the growth of a spontaneous liposarcoma in rats. Int. J. Cancer. 31:1983;223.
15. Kort W. J., Zondervan P. E., Hulsman L. O., Weijma I. M., Westbroek D. L. Incidence of spontaneous tumors in a group of retired breeder female brown Norway rats. J. Natl. Cancer Inst. 72:1984;709.
16. Kramer S. M., Carver M. E. Serum-freein vitro. J. Immunol. Methods. 93:1986;201.
17. Bancroft D. J., Stevens A. Theory and Practice of Histological Techniques. 1986;Churchill Livingstone, New York. p. 402-403.
18. Logan T. F., Kaplan S. S., Bryant J. L., Ernstoff M. S., Krause J. R., Kirkwood J. M. Granulocytopenia in cancer patients treated in a phase I trial with recombinant human tumor necrosis factor. J. Immunother. 10:1991;84.
19. Dvorak H. F., Nagy J. A., Dvorak J. T., Dvorak A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133:1988;95.
20. Nooijen P. T. G. A., Schalkwijk L., Verbeek A. M. M. Transient induction of E selectin expression folowing TNFα based isolated limb perfusion in melanoma and sarcoma patients is not tumor specific. J. Immunother. 19:1996;33.
21. Cotran R. S., Gimbrone M. A. Jr., Bevilacqua M. P., Mendrick D. L., Pober J. S. Induction and detection of a human endothelial activation antigenin vivo. J. Exp. Med. 164:1986;661.
22. Munro J. M., Pober J. S., Cotran R. S. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol. 135:1989;121.
23. Munro J. M., Pober J. S., Cotran R. S. Recruitment of neutrophils in the local endotoxin response: Association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. Lab. Invest. 64:1991;295.
24. Movat H. Z., Burrowes C. E., Cybulsky M. I., Dinarello C. A. Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury. Am. J. Pathol. 129:1987;463.
25. al Attiyah R., Rosen H., Rook G. A. A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations. Clin. Exp. Immunol. 88:1992;537.
26. Chang H. R., Vesin C., Grau G. E. Respective role of polymorphonuclear leukocytes and their integrins (CD-11/18) in the local or systemic toxicity of lipopolysaccharide. J. Leukocyte Biol. 53:1993;636.
27. Dvorak H. F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1986;1650.
28. Havell E. A., Fiers W., North R. J. The antitumor function of tumor necrosis factor (TNFα), I. Therapeutic action of TNFα against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J. Exp. Med. 167:1988;1067.
29. Nawroth P. P., Stern D. M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163:1986;740.
30. Bevilacqua M. P., Rober J. S., Majeau G. R., Fiers W., Cotran R., Gimbrone M. R. Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA. 83:1986;4533.
31. Thurston G., Smith K. A., Murray J. C. Anticoagulant treatment does not affect the action of flavone acetic acid in tumour-bearing mice. Br. J. Cancer. 64:1991;689.
32. Renard N., Nooijen P. T. G. A., Schalkwijk L. VWF release and platelet aggregation in human melanoma after perfusion with TNFα J. Pathol. 176:1995;279.
33. Moake J. L. Haemolytic-uraemic syndrome: Basic science. Lancet. 343:1994;393.
34. Grau G. E., Tacchini-Cottier F., Vesin C. TNFα-induced microvascular pathology: Active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur. Cytokine Netw. 4:1993;415.